EP10.01. Predictors of Survival for Docetaxel as a Subsequent Line after Progression to Platinum-Based Chemotherapy and Immunotherapy - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Virginia Calvo de Juan
Meta Tag
Speaker Virginia Calvo de Juan
Topic Metastatic NSCLC: Cytotoxic Therapy
metastatic non-small cell lung cancer
platinum-based chemotherapy
anti PD1/PD-L1 inhibitors
real-world efficacy
clinical trials
objective response rate
treatment-related toxicity
progression-free survival
overall survival
Powered By